Lorraine Childs
Nurse Practitioner · Tampa, FLNPI 1558498139
Payments from drug & device makers
Across 110 payments — averaging $22.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$453
- Merck$294
- Amgen$248
- Bridgebio Pharma, Inc.$204
- Bayer$144
- United Therapeutics Corporation$103
- plus $992 from 20 others
What the payments were for
- Food & beverage$2,439100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 20 | $453 |
| Merck | 17 | $294 |
| Amgen | 11 | $248 |
| Bridgebio Pharma, Inc. | 4 | $204 |
| Bayer | 6 | $144 |
| United Therapeutics Corporation | 4 | $103 |
| AstraZeneca | 5 | $96 |
| Pfizer | 4 | $95 |
| Esperion Therapeutics, Inc. | 4 | $95 |
| Lexicon Pharmaceuticals, Inc. | 4 | $94 |
| Johnson & Johnson | 5 | $90 |
| Sanofi-aventis U.S. LLC | 4 | $86 |
| Boehringer Ingelheim | 3 | $57 |
| GSK | 3 | $55 |
| Boston Scientific | 2 | $42 |
| Lilly USA, LLC | 2 | $41 |
| Novo Nordisk | 2 | $39 |
| Inspire Medical Systems, Inc. | 1 | $37 |
| Jazz Pharmaceuticals Inc. | 2 | $33 |
| Kiniksa Pharmaceuticals International, PLC | 1 | $26 |
| Scpharmaceuticals Inc. | 1 | $22 |
| E.r. Squibb & Sons, L.L.C. | 1 | $22 |
| Biogen | 1 | $20 |
| Regeneron Healthcare Solutions, Inc. | 1 | $15 |
| Cvrx, Inc. | 1 | $13 |
| Bsn Medical Inc | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Attruby$136
How this compares
$2,439 in reported general payments places this provider in the 85th percentile of 8,290 nurse practitioner providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EntrestoSacubitril/Valsartan | 17 | $26,005 |
| XareltoRivaroxaban | 25 | $25,722 |
| EliquisApixaban | 32 | $25,012 |
| JardianceEmpagliflozin | 24 | $20,805 |
| Nebivolol Hcl | 22 | $1,292 |
| Ezetimibe | 49 | $1,292 |
| Metoprolol Succinate | 44 | $722 |
| Irbesartan | 26 | $574 |
| Atorvastatin Calcium | 36 | $534 |
| Rosuvastatin Calcium | 38 | $490 |
| Doxazosin Mesylate | 15 | $299 |
| Valsartan | 23 | $259 |
| Nitroglycerin | 16 | $231 |
| Carvedilol | 36 | $212 |
| Chlorthalidone | 13 | $206 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| NovartisEntresto | $453 | $26,00517 claims |
| Johnson & JohnsonXarelto | $90 | $25,72225 claims |
| PfizerEliquis | $95 | $25,01232 claims |
| Boehringer IngelheimJardiance | $57 | $20,80524 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 8,290 nurse practitioner providers in Florida.
Other nurse practitioner in Tampa
- April WessonTampa$342K
- Lisa NodzonTampa$246K
- Ashima BahlTampa$226K
- Jennifer PuleoTampa$171K
- Melissa CarverTampa$129K
- Jerrica FariasTampa$127K
- Sara TinsleyTampa$93K
- Erin ParkinsonTampa$65K
- Michele LaineTampa$58K
- Jana BucknerTampa$58K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.